As of 2026-03-30, Vertex Pharmaceuticals（福泰制药）'s data on the DeepSeek platform in the 生命科学 category shows: The overall mention rate is 0.00%, below the industry average by 1.7 percentage points, with significant room for improvement. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. Among 6 competitors in the same category, Vertex Pharmaceuticals（福泰制药）'s overall mention rate surpasses 0 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
Vertex Pharmaceuticals（福泰制药）'s Mention Rate is 0.00%, lower than 0.6% of competitors
Vertex Pharmaceuticals（福泰制药）'s First Mention is 0.00%, lower than 0.9% of competitors
Vertex Pharmaceuticals（福泰制药）'s Preferred Rate is 0.00%, lower than 100.0% of competitors
Vertex Pharmaceuticals（福泰制药）'s Positive Rate is 0.00%, lower than 8.9% of competitors
Vertex Pharmaceuticals（福泰制药）'s Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| AAlnylam Pharmaceuticals | 11.43% | 0% | 0% | 8.57% | 0% | View Details |
| aargenx | 7.14% | 0% | 0% | 7.14% | 0% | View Details |
| CCRISPR Therapeutics | 7.14% | 0% | 0% | 5.71% | 0% | View Details |
| BBioMarin | 7.14% | 0% | 0% | 0% | 7.14% | View Details |
| AAbbVie（艾伯维） | 5.71% | 1.43% | 0% | 5.71% | 0% | View Details |
| RRoche（罗氏） | 5.71% | 0% | 0% | 5.71% | 0% | View Details |
| VVertex Pharmaceuticals（福泰制药） (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
